H.R. 7035 · 117th Congress · House

Biologics Market Transparency Act of 2022

Active· Referred to the Subcommittee on Health.
Introduced
Mar 9, 22
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending
S. 4348
117th Congress
FDASLA Act of 2022

Placed on Senate Legislative Calendar under General Orders. Calendar No. 444.

Related bill
by CRS
Jul 13, 2022
S. 4348
117th Congress
FDASLA Act of 2022

Placed on Senate Legislative Calendar under General Orders. Calendar No. 444.

Related bill
by CRS
Jul 13, 2022
H.R. 7667
117th Congress
Food and Drug Amendments of 2022

Received in the Senate.

Related bill
by CRS
Jun 9, 2022
H.R. 7667
117th Congress
Food and Drug Amendments of 2022

Received in the Senate.

Related bill
by CRS
Jun 9, 2022
S. 4302
117th Congress
Biologics Market Transparency Act of 2022

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)

Related bill
by CRS
May 25, 2022
S. 4302
117th Congress
Biologics Market Transparency Act of 2022

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)

Related bill
by CRS
May 25, 2022